Background Autism spectrum disorders (ASD) occur in 1.5% of the general population
worldwide. Studies suggest that ASD might have more costs than diabetes and attention …

Pediatric acute-onset neuropsychiatric syndrome (PANS) features a heterogeneous
constellation of acute obsessive-compulsive disorder (OCD), eating restriction, cognitive …

Autism spectrum disorders (ASD) are a group of heterogeneous neurodevelopmental
conditions characterized by impaired social interaction, and repetitive stereotyped …

Background Autism spectrum disorder (ASD) might be associated with oxidative stress, and
antioxidants are commonly used in the treatment of young people with ASD. However, the …

Background Primary negative symptoms of schizophrenia are usually resistant to
monotherapy with antipsychotics. The present study sought to assess the efficacy and …

Background Autism Spectrum Disorders (ASD) are defined as a group of pervasive
neurodevelopmental disorders, and the heterogeneity in the symptomology and etiology of …

Recent findings have led to the discovery of many signaling pathways that link nuclear
receptors with human conditions, including mental decline and neurodegenerative …

Introduction Autism spectrum disorder (ASD) is an early-onset disorder with a prevalence of
1% among children and reported disability-adjusted life years of 4.31 million. Irritability is a …

Autism spectrum disorder (ASD) is a neurodevelopmental disorder, affecting communication
and behavior. Historically, ASD had been described as a purely psychiatric disorder with …

This is a double-blind, placebo-controlled randomized trial to investigate the potential
therapeutic effects of folinic acid/placebo as an adjuvant to risperidone on inappropriate …